Reviva Pharmaceuticals Holdings, Inc.RVPHNASDAQ
Loading
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q3 2025 | 33.64% |
| Q2 2025 | 7.11% |
| Q1 2025 | -4.03% |
| Q4 2024 | 25.74% |
| Q3 2024 | -4.09% |
| Q2 2024 | -2.62% |
| Q1 2024 | 20.69% |
| Q4 2023 | 6.73% |
| Q3 2023 | 11.28% |
| Q2 2023 | -79.21% |
| Q1 2023 | 13.36% |
| Q4 2022 | -118.19% |
| Q3 2022 | 35.45% |
| Q2 2022 | 25.91% |
| Q1 2022 | -87.91% |
| Q4 2021 | -60.07% |
| Q3 2021 | -38.36% |
| Q2 2021 | 4.38% |
| Q1 2021 | -255.45% |
| Q4 2020 | -2.81% |
| Q3 2020 | 34.10% |
| Q2 2020 | -25.73% |
| Q1 2020 | -272.41% |
| Q4 2019 | -76.41% |
| Q3 2019 | -32.30% |
| Q2 2019 | 58.36% |
| Q1 2019 | -115.84% |
| Q4 2018 | -3299.79% |
| Q3 2018 | 82.55% |
| Q2 2018 | 0.00% |